Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 138 publications.

Poulos C, Gebben D, Peay H, Saha A, Vaezy S, Pierce A, Pina I, Farb A, Moultrie R, Babalola O, Tarver ME. Benefit-risk preferences of patients for the use of artificial intelligence and ultrasound imaging in different settings in echocardiography. Poster presented at the ISPOR 2023 Conference; May 7, 2023.

Poulos C, Mansfield C, Bussberg CJ, Hicks JC, Downey C. Advancing equity, diversity, inclusion, and belonging in patient centered drug development with patient preference research. Poster presented at the ISPOR 2023 Conference; May 7, 2023.

Poulos C, Pierce A, Chintakayala PK. A review of the influence of stakeholder preference research on the EtR framework. Poster presented at the ISPOR 2023 Conference; May 7, 2023.

McMichael A, Poulos C, Vass C, Boeri M. A literature review assessing the most common attributes used in stated-preference studies assessing influenza vaccination: do we know what health care professionals value? Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA.

Stothers Rosenberg S, Ng X, Mansfield C, Poulos C, Peay H, Lee TH, Irony T, Ho M. Adaptation of the WOMAC for use in a patient preference study. Ther Innov Regul Sci. 2023 Apr 15. doi: 10.1007/s43441-023-00510-8

Vass C, Pinto CA, Myers K, Imai K, Bussberg C, Bhattacharya R, Calhoun SR, Poulos C. Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: evidence from latent class analysis. Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Franciso, CA. [abstract] J Clin Oncol. 2023 Feb 20; 41(Suppl 6):661. doi: 10.1200/JCO.2023.41.6_suppl.661

Calhoun SR, Vass C, Myers K, Imai K, Bussberg C, Bhattacharya R, Pinto CA, Poulos C. Patient and physician preferences for adjuvant treatment of renal cell carcinoma: a discrete-choice experiment. Poster presented at the 2023 ASCO Genitourinary Cancers Symposium; February 16, 2023. San Franciso, CA. [abstract] J Clin Oncol. 2023 Feb 20; 41(Suppl 6):635. doi: 10.1200/JCO.2023.41.6_suppl.635

Kandzari DE, Weber MA, Poulos C, Coulter J, Cohen SA, DeBruin V, Jones D, Pathak A. Patient preferences for pharmaceutical and device-based treatments for uncontrolled hypertension: discrete choice experiment. Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e008997. doi: 10.1161/CIRCOUTCOMES.122.008997

Poulos C, Xu Y, Botha W, Leach C, Wrobleski KK, Gordon K, Missmer SA, Estes SJ. A discrete-choice experiment study of physicians' prioritization of attributes of medical treatments for endometriosis-associated pain. Expert Rev Pharmacoecon Outcomes Res. 2023 Jan;23(1):111-21. doi: 10.1080/14737167.2023.2152006

Poulos C, Boeri M, Coulter JR, Huang L, Schley K, Pugh SJ. Travelers' preferences for tick-borne encephalitis vaccination. Expert Rev Vaccines. 2022 Oct 1;21(10):1495-504. doi: 10.1080/14760584.2022.2108798

Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in stated preferences for health care. Journal of choice modelling. 2022 Sep;44. doi: 10.1016/j.jocm.2022.100367

Gilsenan A, Juhaeri J, Poulos C, Levitan B. Weighting the benefits & risks: the science and methods of benefit-risk assessment in drug development. Presented at the 2022 ICPE Conference; August 25, 2022. Copenhagen, Denmark.

Myers KH, Poulos C, Pierce AM. Atopic dermatitis patients prefer skin clearance outcomes, topical therapy. Poster presented at the Society of Dermatology Physician Assistants Annual Summer Dermatology Conference; June 20, 2022. Austin, TX.

Poulos C, Ng X, Mansfield C, Rosenberg S, Peay H, Lee J, Irony T, Ho M. Logical soundness in a discrete choice experiment study of benefit risk preferences. Presented at the ISPOR 2022 Conference; May 15, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Bridges JFP, Poulos C, Andrew Finkelstein E. Measuring health preferences of multiple stakeholders: issues and challenges. Presented at the ISPOR 2022 Conference; May 2022. Washington, DC.

Kandzari DE, Weber MA, Poulos C, Cohen SA, Jones D, Pathak A. Patient preferences for interventional and pharmaceutical treatments among U.S. adults with uncontrolled hypertension. Presented at the Virtual Transcatheter Cardiovascular Therapeutics (TCT) Conference; November 4, 2021.

Ng X, Stothers S, Mansfield C, Poulos C, Peay H, Lee TS, Irony T, Ho M. Adaptation of the Western Ontario McMaster Universities (WOMAC) osteoarthritis index for use in a patient preference study to inform regulatory decision-making. Poster presented at the 2021 SMDM Virtual Annual Meeting; October 19, 2021.

Estes SJ, Poulos C, Xu Y, Botha W, Leach CA, Wrobleski KK, Gordon K, Missmer SA. A discrete choice experiment study of physicians' preference for treatments for endometriosis-associated pain - fertility and sterility (fertstert.org). Presented at the 2021 American Society for Reproductive Medicine Scientific Congress & Expo; October 17, 2021. Baltimore, MD. [abstract] Fertil Steril. 2021 Sep 1; 116(3):e205. doi: 10.1016/j.fertnstert.2021.07.561

Patterson BJ, Myers K, Stewart A, Mange B, Hillson EM, Poulos C. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment. Expert Rev Vaccines. 2021 Jul 22. doi: 10.1080/14760584.2021.1910502

Vass CM, Boeri M, Poulos C, Turner AJ. Matching and weighting in health preference research. Presented at the 2021 Virtual 12th Meeting of the International Academy of Health Preference Research; June 2021. [abstract] Patient. 2021 Jun 18; p.1-6. doi: 10.1007/s40271-021-00532-0

Reed S, Bocell F, Weinfurt K, Poulos C. From PROMs to PPI: a roadmap for incorporating PROMs into PPI studies for regulatory decision-making. Presented at the Virtual ISPOR 2021 Conference; May 2021.

Jeuland M, McClatchey M, Patil SR, Pattanayak SK, Poulos CM, Chen Yang J. Do decentralized community treatment plants provide clean water? Evidence from rural Andhra Pradesh, India. Land Econ. 2021 May;97(2).

Feldman SR, Poulos C, Gilloteau I, Mange B, Boehm K, Boeri M, Naatz M, Augustin M. Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and Germany. J Dermatolog Trea. 2021 Feb 3;1-10. doi: 10.1080/09546634.2020.1839007

Bell CF, Lau M, Lee M, Poulos C. Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE. Clin Rheumatol. 2021 Feb;40(2):581-90. doi: 10.1007/s10067-020-05226-w

Poulos C, Soliman AM, Tekin S, Agarwal SK. Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States. Expert Rev Pharmacoecon Outcomes Res. 2020 Nov 3;1-9. doi: 10.1080/14737167.2021.1832468

Harfe D, Liden B, Poulos C, Snell T, Brown-Smith K, Tarver M. Case studies for use of PPI in medical device decision-making processes. Presented at the Virtual ISPOR-FDA Summit 2020; September 29, 2020.

Irony T, Gonzalez Sepulveda JM, Poulos C, Wilson L. Three FDA CBER-sponsored quantitative patient preference studies of biologic treatments to inform regulatory decision making. Presented at the 2020 DIA Virtual Conference; June 15, 2020. Washington, DC.

Myers K, Klein K, Mansfield C, Poulos C. A review of the use of comprehension questions in health preference studies. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S319-20. doi: 10.1016/j.jval.2020.04.1189

Vass C, Boeri M, Poulos C. Association between access device and stated preferences for health care. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1;. doi: 10.1016/j.jval.2020.04.1183

Poulos C, Vass C, Klein K, Boeri M. Scope tests in health care discrete choice experiments. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S320. doi: 10.1016/j.jval.2020.04.094

Poulos C, Hauber B, Mirzaei F, Dilley A, DeMuro C, Fillit HM. A study of preferences for disease-modifying treatments for Alzheimer's Disease. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S278. doi: 10.1016/j.jval.2020.04.1189

Mansfield C, Poulos C, Ho M. Using patient-reported outcomes in the design of stated preference surveys: challenges and opportunities. Presented at the 2020 ISPOR Virtual Conference; May 2020.

Poulos C, Wakeford C, Kinter E, Mange B, Schenk T, Jhaveri M. Patient and physician preferences for multiple sclerosis treatments in Germany: a discrete-choice experiment study. Mult Scler J Exp Transl Clin. 2020 Jan;9(2):1-14. doi: 10.1177/2055217320910778

Mansfield C, Poulos C, Boeri M, Hauber B. Performance of a comprehension question in discrete-choice experiment surveys (DCE). Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).

Sacco P, Myers K, Poulos C, Sweeney C, Hollis K, Snow V, Vietri JT. Preferences for adult pneumococcal vaccine recommendations among United States health care providers. Infect Dis Ther. 2019 Dec;8(4):657-70. doi: 10.1007/s40121-019-00266-5

Augustin M, Feldman S, Poulos C, Gilloteau I, Mange B, Boeri M, Boehm K, Melzer N, Gutknecht M. Patient preferences for treatment of moderate to severe psoriasis: a discrete choice experiment study in Germany. Poster presented at the 28th European Academy of Dermatology and Venereology (EADV) Congress; October 11, 2019. Madrid, Spain.

Poulos C, Wakeford C, Kinter E, Mange B, Schenk T. Preferences of patients for features of injectable, oral, and infused disease-modifying treatments for relapse-remitting multiple sclerosis. Poster presented at the 2019 ISPOR Latin America Conference; September 13, 2019. Bogota, Colombia.

Bullok KE, Hauber AB, Mansfield CA, DiSantostefano RL, Poulos C. Patient preferences: using conjoint analysis and stated preferences in drug development and regulatory decision making. Presented at the DIA 2019 Global Annual Meeting; June 23, 2019. San Diego, CA.

Poulos C, Soliman AM, Renz CL, Posner J, Agarwal SK. Patient preferences for endometriosis pain treatments in the United States. Value Health. 2019 Jun;22(6):728-38. doi: 10.1016/j.jval.2018.12.010

Feldman S, Poulos C, Gilloteau I, Mange B, Germino B, Boehm K, Gutknecht M, Augustin M. Patient preferences for treatment of moderate-to-severe psoriasis: a U.S. discrete-choice experiment survey. Poster presented at the 2019 American Academy of Dermatology (AAD) Annual Meeting; March 2, 2019. Washington, DC.

Poulos C, Feldman SR, Gilloteau I, Boeri M, Guana A, Germino B, Boehm K, Gutknecht M, Augustin M. The most influential drivers of psoriasis patients' treatment choice: a discrete choice experiment survey in the US. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 12, 2018. Barcelona, Spain.

Poulos C, Wakeford C, Kinter E, Mange B, Schenk T. Preferences of German physicians for features of injectable, oral, and infused disease-modifying treatments for relapsing-remitting multiple sclerosis. Poster presented at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); October 10, 2018. Berlin, Germany.

Poulos C, Standaert B, Sloesen B, Stryjewska I, Janitsary A, Hauber B. Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary. Vaccine. 2018 Sep 25;36(40):6022-9. doi: 10.1016/j.vaccine.2018.08.001

Poulos C, Soliman A, Renz C, Posner J, Bhattacharya M, Agarwal SK. A discrete choice experiment study of patient preferences regarding treatments for endometriosis-associated pain. Poster presented at the ASRM 2018 Scientific Congress & Expo; October 10, 2018. Denver, CO. [abstract] Fertil Steril. 2018 Sep; 110(4 Supplement):e389. doi: 10.1016/j.fertnstert.2018.07.1087

Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers' preferences for travel vaccines assessed by a discrete choice experiment. Vaccine. 2018 Feb 8;36(7):969-78.

Poulos C, Kinter E, Van Beek J, Christensen K, Posner J. Preferences of patients with multiple sclerosis for attributes of injectable multiple sclerosis treatments in the United Kingdom and France. Int J Technol Assess Health Care. 2018 Jan;34(4):425-33. doi: 10.1017/S0266462318000491

Mansfield C, Sikirica MV, Pugh A, Poulos CM, Unmuessig V, Morano R, Martin AA. Patient preferences for attributes of type 2 diabetes mellitus medications in Germany and Spain: an online discrete-choice experiment survey. Diabetes Ther. 2017 Dec;8(6):1365-78. doi: 10.1007/s13300-017-0326-8

Poulos C, Standaert B, Sloesen B, Hauber AB. What motivates mothers to pay for a vaccine against children's diarrhea? Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419.

Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers' preferences for vaccines against travel-related illnesses. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419-20.

Mamounas E, Poulos C, Goertz HP, Gonzalez JM, Pugh A, Antao V. Neoadjuvant systemic therapy for breast cancer: factors influencing surgeons' referrals. Ann Surg Oncol. 2016 Oct;23(11):3510-7. doi: 10.1245/s10434-016-5296-y